(Q39465836)
Statements
Preparation and preclinical evaluation of 177Lu-nimotuzumab targeting epidermal growth factor receptor overexpressing tumors (English)
Denis R Beckford Vera
Sebastian Eigner
Katerina Eigner Henke
Frantisek Melichar
29 September 2011